Newsfeeds Archive - Page 408 of 461

1 minute read

Goldman Sachs Rolls Out Transaction Banking Services In Europe

September 20, 8:07 AM

Goldman Sachs Group Inc (NYSE: GS) has launched transaction banking services, specializing in services for corporate treasuries, in Europe in a bid to diversify beyond its trading and advice services.

1 minute read

China-Based COVID-19 Shot Neutralizes Omicron Subvariants

By Vandana Singh

September 20, 7:29 AM

China-based Clover Biopharmaceuticals Ltd announced data from its ongoing Phase 3 study evaluating SCB-2019 (CpG 1018/Alum) as a universal COVID-19 booster…

DVAX

1 minute read

Judge Says Yes To $13B UnitedHealth-Change Healthcare Merger: Report

By Vandana Singh

September 20, 7:18 AM

A U.S. judge on Monday denied the Justice Department's request to stop UnitedHealth Group Inc's (NYSE: UNH) $13 billion buyout deal for Change Healthcare Inc (NASDAQ: CHNG).

CHNG

1 minute read

Multiple Sclerosis Is A Crowded Space, But This Stock Is A Potential 6X Multi-bagger

By Vandana Singh

September 19, 3:03 PM

HC Wainwright assumes coverage on Immunic Inc (NASDAQ:IMUX), a late-stage clinical biotech company developing oral small molecule inhibitors for multiple sclerosis (MS)…

IMUX

1 minute read

Analyst Builds Bullish Case For This Neuromuscular Company, Sees 200% Upside

By Vandana Singh

September 19, 2:39 PM

HC Wainwright has assumed coverage on Scholar Rock Holding Corp (NASDAQ:SRRK) with a Buy rating and price target of $30. The analyst writes…

SRRK

1 minute read

Theravance Outlines $250M Capital Return Program; To Repurchase GSK’s Entire Holdings

By Vandana Singh

September 19, 2:28 PM

Theravance Biopharma Inc (NASDAQ:TBPH) is buying back over 9.6 million shares from GSK plc (NYSE:GSK) for roughly $94 million, according to an…

GSK

1 minute read

HC Wainwright Sees 40% Upside For This Once Battered Stock With Pipeline Turnaround

By Vandana Singh

September 19, 2:02 PM

HC Wainwright is assuming coverage on AnaptysBio Inc (NASDAQ:ANAB) with a Buy Rating and a price target of $35 at a unique inflection…

ANAB

1 minute read

Genfit To Buy This Swiss Firm Expanding Its Portfolio in Liver Diseases

By Vandana Singh

September 19, 12:42 PM

Genfit SA (NASDAQ:GNFT) has agreed to acquire the Swiss startup Versantis for CHF40 million upfront in a small-time buyout. The deal,…

GNFT

1 minute read

McKesson Buys Rx Savings Solutions For $875M

By Vandana Singh

September 19, 11:57 AM

McKesson Corp (NYSE:MCK) has agreed to acquire Rx Savings Solutions (RxSS), a prescription price transparency and benefit insight company offering affordability and…

MCK

1 minute read

Beam Therapeutics Touts Encouraging Preclinical Data From Gene Editing Approach For Hepatitis B Infection

By Vandana Singh

September 19, 11:49 AM

Beam Therapeutics Inc (NASDAQ:BEAM) announced new preclinical data demonstrating the potential of its multiplex base editing approach to reduce hepatitis B…

BEAM